Randomized Controlled Trial
Copyright ©The Author(s) 2022.
World J Clin Cases. Jul 16, 2022; 10(20): 6890-6899
Published online Jul 16, 2022. doi: 10.12998/wjcc.v10.i20.6890
Table 2 Details of anesthesia, adverse effects, and neonatal outcomes

EA (n = 57)
DPE (n = 58)
Z/t/χ2
95%CI of difference
P value
The onset time to T6 level (min)16.6 (15.8-17.4)14.7 (13.9-15.4)4.039-5.0, 0.00.0012
Maximum sensory level (T)5 (4-6)5 (4-5)1.1200.0, 1.00.2632
Modified bromage score to 3, n (%)21 (36.8)45 (77.6)19.5162.6, 13.5< 0.001
Cranial sensory block to T6, n (%)30 (52.6)54 (93.1)23.9153.8, 38.0< 0.001
Vasopressor administration, n (%)6 (10.5)9 (15.5)0.6310.5, 4.70.4273
Intraoperative IV analgesic supplementation, n (%)16 (28.1)7 (12.1)4.6000.1, 0.90.0323
Local anesthetic volume (ml)20.0 (17.5-20.0)20.0 (15.0-20.0)0.4290.0, 0.00.6682
Fluid administration (ml)800.0 (750.0-800.0)800.0 (700.0-800.0)0.8060.0, 0.00.4242
Estimated blood loss (ml)400.0 (400.0-400.0)400.0 (300.0-400.0)1.5480.0, 0.00.1222
Duration of surgery (min)37.4 ± 8.336.3 ± 6.30.746-3.7, 1.70.4571
Urine output (ml)100.0 (100.0-150.0)100.0 (100.0-150.0)0.2480.0, 0.00.8042
Adverse effects, n (%)
Hypotension5 (8.8)2 (3.5)1.4250.1, 2.00.4223
Respiratory depression0 (0.0)0 (0.0)0.0000.0, 0.01.0003
Postdural headache0 (0.0)0 (0.0)0.0000.0, 0.01.0003
Nausea and vomiting7 (12.3)5 (8.6)0.4120.2, 2.30.5213
Chest distress5 (8.8)7 (12.1)0.3340.4, 4.80.5633
Dizzy6 (10.5)4 (6.9)0.4770.2, 2.40.7193
Nasal obstruction5 (8.8)6 (10.3)0.0820.3, 4.20.7743
Chills19 (33.3)14 (24.1)1.1880.3, 1.40.2763
Neonatal outcomes
Apgar score < 8 at 1 min, n (%)3 (5.3)2 (3.4)0.0000.1, 4.00.9843
Apgar score < 8 at 5 min, n (%)0 (0.0)0 (0.0)0.0000.0, 0.01.000